<DOC>
	<DOCNO>NCT01366833</DOCNO>
	<brief_summary>According Canadian Cancer Society approximately 1700 new case esophageal cancer per year Canada . As patient diagnose advanced stage disease , 1800 death estimate cancer annually . Progressive dysphagia common present symptom impact patient 's quality life ability tolerate life prolong treatment systemic chemotherapy . Although several therapeutic modality alleviate malignant dysphagia include laser , photodynamic therapy cryotherapy , use stent radiotherapy commonly employ . However , optimal approach effective , timely treatment malignant dysphagia remain challenge . The investigator conduct preliminary retrospective review investigate palliation procedure find multi-modality approach may yield favourable result . Therefore , clinical trial examine effectiveness add single dose brachytherapy patient severe dysphagia already treat endoscopically place self-expanding metallic stent .</brief_summary>
	<brief_title>Optimal Management Malignant Dysphagia</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Deglutition Disorders</mesh_term>
	<criteria>Age ≥18 year Confirmed esophageal/gastroesophageal ( GEJ ) cancer ( Siewert Type I Type II ) histology biopsy Dysphagia score ≥2 Stage IV cancer/Metastatic disease Expected life expectancy &lt; 3 month Inability undergo stent insertion Siewert Type III gastroesophageal cancer EsophagealAirway fistula</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Dysphagia</keyword>
	<keyword>Esophagus</keyword>
	<keyword>Cancer</keyword>
	<keyword>Esophageal Cancer</keyword>
</DOC>